Shigeru Kanda is a Head of the Department of Experimental and Clinical Laboratory Medicine at the National Hospital Organization Nagasaki Hospital, Nagasaki, Japan. He received his M.D. and Ph.D. degrees from the Nagasaki University School of Medicine, Japan, in 1983 and in 1991, respectively. He awarded the research bounty from the Japanese Urological Association in 1993 (studies of growth factors involved in renal tubular cell regeneration). He trained in basic cellular biochemistry at the Enzyme Research Center, Tokushima University, Tokushima, Japan, and in molecular and cellular biology at Ludwig Institute for Cancer Research, Uppsala Branch, Uppsala, Sweden. He worked at the Nagasaki University Graduate School of Biomedical Sciences as an Associate Professor and then moved to the Nagasaki Hospital. He is studying the signal transduction pathways leading to angiogenesis and metastatic spread of tumor cells for the development and the improvement of molecular targeting therapies to manage advanced cancer patients including palliation of undesirable symptoms.
Biography Updated on 4 December 2011